Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands and maintain these improvements for one year, according to a study to be presented at the American Stroke Association’s International Stroke Conference 2024.
Roche’s tiragolumab flops in another Phase III lung cancer trial – Pharmaceutical Technology
Shares in Roche opened 0.55% lower at market open following the news. Image credit: Shutterstock / Marlon Trottmann. Roche’s struggles with finding a foothold for
November 26, 2024